It has been utilized in neurodegenerative diseases to analyse brain volume changes in T1-weighted images, white matter degeneration in diffusion tensor images and amyloid or tau accumulation in PET scans.26-30 However, studies employing SuStaIn for myotonic dystrophy Type 1 are lacking. Here, MAPT is linked to myotonic dystrophy type 1.